Evaluation of serum MicroRNA 21, MicroRNA 192 and serum TGFβ1 in type 2 diabetes mellitus patients and their relation to diabetic nephropathy

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Abou Eleila J.G.; Abdel Wahab Mohamed A.; Waked E.A.; Kamel L.N.; Shawky Amin H.; Elhanafi H.M.

Journal: Egyptian Journal of Medical Human Genetics

Publisher: Springer Nature

Publication Date: 8 July 2024

Volume / Issue: Volume 25 / Issue 1

Article No.: 80

ISSN: 11108630

DOI: 10.1186/s43042-024-00544-z

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Gold Open Access; Green Open Access


Authors and Affiliations

Abou Eleila J.G., Department of Clinical Chemistry, Theodor Bilharz Research Institute, Giza, Egypt; Abdel Wahab Mohamed A., Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt; Waked E.A., Department of Nephrology, Theodor Bilharz Research Institute, Giza, Egypt; Kamel L.N., Department of Clinical Chemistry, Theodor Bilharz Research Institute, Giza, Egypt; Shawky Amin H., Department of Clinical Chemistry, Theodor Bilharz Research Institute, Giza, Egypt; Elhanafi H.M., Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt


Abstract

Background: Diabetic nephropathy (DN) is a frequent and long-lasting microvascular consequence that has an established connection with diabetes. It serves as the primary etiological agent of end-stage renal disease, a critical renal disorder that develops on a worldwide level. The molecular pathophysiology of DN is multifactorial, such as transforming growth factor-beta [TGF-β] which affects the expression of miRNAs such as miRNA-21 and miRNA-192 during renal fibrosis. However, to date, the clinical application is inadequate due to discrepancies observed in the published data. This cross-sectional investigation aimed to assess the correlation between serum TGF-β1, miRNA-21 and 192, and glycemic control, metabolic abnormalities, and renal function in patients with type II diabetes. Methods: Based on the albumin/creatinine ratio (ACR), fifty subjects with type II diabetes were divided into three categories: Group I consisted of individuals with normoalbuminuria (n = 16), Group II of microalbuminuria (n = 16), and Group III of overt proteinuria (n = 18). All participants were subjected to the estimation of mature miRNA-21 and miRNA-192 by TaqMan two-step stem loop qRT-PCR and serum TGFβ1 level by ELISA. Results: There was an upregulation in miRNA-21 expression in the 3 different groups of patients (p value = 0.043). The serum fold change (FC) of miRNA-21 showed significantly greater median values in patients with overt proteinuria compared to those with normoalbuminuria (5.57 FC versus 1.11 FC, p = 0.017). A positive correlation (r = 0.343) (p = 0.013) was observed between the ACR and the median levels of miRNA-21, which was statistically significant. No statistically significant distinctions were detected in the concentrations of serum TGF-β1 or miRNA-192 among the three patient groups (p values of 0.234 and 0.225, respectively). Conclusion: The findings of the present research implied that miRNA-21 might function as an early indicator of renal pathology associated with diabetes mellitus (DM). © The Author(s) 2024.


Keywords

Diabetic nephropathy; miR192; miR21; TGF-β; complementary DNA; glucose; hemoglobin A1c; high density lipoprotein; low density lipoprotein; microRNA 192; microRNA 21; transforming growth factor beta1; triacylglycerol; adult; albumin to creatinine ratio; Article; body mass; cholesterol blood level; clinical article; controlled study; cross-sectional study; diabetic patient; end stage renal disease; enzyme linked immunosorbent assay; female; glucose blood level; glycemic control; human; kidney fibrosis; kidney function; male; microalbuminuria; middle aged; non insulin dependent diabetes mellitus; proteinuria; real time polymerase chain reaction; real time reverse transcription polymerase chain reaction; triacylglycerol blood level; upregulation


Citation Information

Scopus Citations: 9


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

Transcriptome analysis for Schistosoma vector snail’s Oncomelania hupensis exposed to silver nanoparticles

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer